BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11950549)

  • 41. Prevalence of alcohol and drug abuse in schizophrenic inpatients.
    Soyka M; Albus M; Kathmann N; Finelli A; Hofstetter S; Holzbach R; Immler B; Sand P
    Eur Arch Psychiatry Clin Neurosci; 1993; 242(6):362-72. PubMed ID: 8323987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample.
    McLean D; Gladman B; Mowry B
    Aust N Z J Psychiatry; 2012 Feb; 46(2):132-40. PubMed ID: 22311529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
    Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization.
    Mason P; Harrison G; Glazebrook C; Medley I; Croudace T
    Br J Psychiatry; 1996 Nov; 169(5):580-6. PubMed ID: 8932886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ABC Schizophrenia study: an overview of results since 1996.
    Häfner H; Maurer K; an der Heiden W
    Soc Psychiatry Psychiatr Epidemiol; 2013 Jul; 48(7):1021-31. PubMed ID: 23644725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
    Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronology of comorbid and principal syndromes in first-episode psychosis.
    Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
    Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Elbogen EB; Johnson SC
    Arch Gen Psychiatry; 2009 Feb; 66(2):152-61. PubMed ID: 19188537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Impact of alcohol dependence on the course and psychopathology of schizophrenia].
    Konarzewska B; Popławska R; Galińska B; Szulc A; Markowski T
    Psychiatr Pol; 2007; 41(5):715-26. PubMed ID: 18421926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.
    Harrison I; Joyce EM; Mutsatsa SH; Hutton SB; Huddy V; Kapasi M; Barnes TR
    Psychol Med; 2008 Jan; 38(1):79-88. PubMed ID: 17532864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double jeopardy: schizophrenia and substance use.
    Swofford CD; Scheller-Gilkey G; Miller AH; Woolwine B; Mance R
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):343-53. PubMed ID: 10976661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Homicide, schizophrenia and substance abuse: a complex interaction].
    Richard-Devantoy S; Bouyer-Richard AI; Jollant F; Mondoloni A; Voyer M; Senon JL
    Rev Epidemiol Sante Publique; 2013 Aug; 61(4):339-50. PubMed ID: 23816066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comorbid substance use and age at onset of schizophrenia.
    Barnes TR; Mutsatsa SH; Hutton SB; Watt HC; Joyce EM
    Br J Psychiatry; 2006 Mar; 188():237-42. PubMed ID: 16507965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
    Strakowski SM; Tohen M; Flaum M; Amador X
    Schizophr Res; 1994 Dec; 14(1):73-81. PubMed ID: 7893624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
    Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
    Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Is there a temporal correlation between substance abuse and psychosis in adolescents?].
    Holtmann M; Becker K; Hartmann M; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):97-103. PubMed ID: 12053879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.
    Poirier S; Legris G; Tremblay P; Michea R; Viau-Guay L; Mérette C; Bouchard RH; Maziade M; Roy MA
    Schizophr Res; 2010 May; 118(1-3):285-91. PubMed ID: 20096540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.